Compare GASS & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GASS | CLPT |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.1M | 353.5M |
| IPO Year | 2005 | 2009 |
| Metric | GASS | CLPT |
|---|---|---|
| Price | $10.10 | $11.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 94.6K | ★ 439.3K |
| Earning Date | 05-27-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | $5.00 | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $5.22 | $8.27 |
| 52 Week High | $10.52 | $30.10 |
| Indicator | GASS | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 66.44 | 54.23 |
| Support Level | $8.66 | $10.02 |
| Resistance Level | $10.52 | $11.79 |
| Average True Range (ATR) | 0.29 | 0.70 |
| MACD | 0.08 | 0.10 |
| Stochastic Oscillator | 92.97 | 61.08 |
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.